Lynch Brian Joseph has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 3639 shares of MADRIGAL PHARMACEUTICALS, INC. ($MDGL) on January 23, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Lynch Brian Joseph | SVP and General Counsel | A | Common Stock | 3639 | $0.00 | 18,221.0000 | 0 | 24.96% | 0.00% |
| Jan. 23, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Lynch Brian Joseph | SVP and General Counsel | A | Stock Option (Right to Buy) | 5483 | $0.00 | 5,483.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Lynch Brian Joseph | SVP and General Counsel | A | Market Stock Unit | 3639 | $0.00 | 3,639.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Lynch Brian Joseph | SVP and General Counsel | F | Common Stock | 949 | $243.92 | 14,582.0000 | 0 | 6.11% | 0.00% |